Literature DB >> 26576642

H295R expression of melanocortin 2 receptor accessory protein results in ACTH responsiveness.

Kazutaka Nanba1, Andrew X Chen1, Adina F Turcu1, William E Rainey2.   

Abstract

The H295R adrenocortical cell line is widely used for molecular analysis of adrenal functions but is known to have only modest ACTH responsiveness. The lack of ACTH response was linked to a low expression of its receptor, melanocortin 2 receptor (MC2R). We hypothesized that increasing the MC2R accessory protein (MRAP), which is required to traffic MC2R from the endoplasmic reticulum to the cell surface, would increase ACTH responsiveness. Lentiviral particles containing human MRAP-open reading frame were generated and transduced in H295R cells. Using antibiotic resistance, 18 clones were isolated for characterization. The most ACTH-responsive steroidogenic clone, H295RA, was used for further experiments. Successful induction of MRAP and increased expression of MC2R in H295RA cells was confirmed by quantitative real-time RT-PCR and protein analysis. Treatment with ACTH significantly increased aldosterone, cortisol, and dehydroepiandrosterone production in H295RA cells. ACTH also significantly increased transcript levels for all of the steroidogenic enzymes required to produce aldosterone, cortisol, and dehydroepiandrosterone, as well as MC2R mRNA. Using liquid chromatography/tandem mass spectrometry, we further revealed that the main unconjugated steroids produced in H295RA cells were 11-deoxycortisol, cortisol, and androstenedione. Treatment of H295RA cells with ACTH also acutely increased cAMP production and cellular protein levels for total and phosphorylated steroidogenic acute regulatory protein. In summary, through genetic manipulation, we have developed an ACTH-responsive human adrenocortical cell line. The cell line will provide a powerful in vitro tool for molecular analysis of physiologic and pathologic conditions involving the hypothalamic-pituitary-adrenal axis.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  ACTH; H295R; MC2R; MRAP; cell line

Mesh:

Substances:

Year:  2015        PMID: 26576642     DOI: 10.1530/JME-15-0230

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  5 in total

1.  Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing Adenoma.

Authors:  Kazutaka Nanba; Amy R Blinder; Juilee Rege; Namita G Hattangady; Tobias Else; Chia-Jen Liu; Scott A Tomlins; Pankaj Vats; Chandan Kumar-Sinha; Thomas J Giordano; William E Rainey
Journal:  Hypertension       Date:  2020-01-27       Impact factor: 10.190

2.  Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro.

Authors:  Juilee Rege; Aya T Nanba; Richard J Auchus; Jianwei Ren; Hwei-Ming Peng; William E Rainey; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

3.  GATA transcription factors in testicular adrenal rest tumours.

Authors:  Manon Engels; Paul N Span; Rod T Mitchell; Joop J T M Heuvel; Monica A Marijnissen-van Zanten; Antonius E van Herwaarden; Christina A Hulsbergen-van de Kaa; Egbert Oosterwijk; Nike M Stikkelbroeck; Lee B Smith; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  Endocr Connect       Date:  2017-10-16       Impact factor: 3.335

4.  Development of new preclinical models to advance adrenocortical carcinoma research.

Authors:  Katja Kiseljak-Vassiliades; Yu Zhang; Stacey M Bagby; Adwitiya Kar; Nikita Pozdeyev; Mei Xu; Katherine Gowan; Vibha Sharma; Christopher D Raeburn; Maria Albuja-Cruz; Kenneth L Jones; Lauren Fishbein; Rebecca E Schweppe; Hilary Somerset; Todd M Pitts; Stephen Leong; Margaret E Wierman
Journal:  Endocr Relat Cancer       Date:  2018-01-25       Impact factor: 5.678

5.  Interaction between Angiotensin II and Insulin/IGF-1 Exerted a Synergistic Stimulatory Effect on ERK1/2 Activation in Adrenocortical Carcinoma H295R Cells.

Authors:  An-Li Tong; Fen Wang; Yun-Ying Cui; Chun-Yan Li; Yu-Xiu Li
Journal:  Int J Endocrinol       Date:  2016-05-12       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.